Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
S. Nava (Bologna (BO), Italy). PRO - Steroids in ARDS. Respiratory Failure and Mechanical Ventilation Conference 2020

Member's Comments

No comment yet.

Related content which might interest you: PRO - Lung biopsy in ARDS Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 PRO - NIV in acute hypoxemic failure Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 NIV and pneumonia - PRO & CON Source: ERS course 2015 Year: 2015 CON - Steroids in ARDS Source: Respiratory Failure and Mechanical Ventilation Conference 2020 Year: 2020 Debate: Bacteria are a cause of acute bronchitis - PRO Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008 Debate: Antibiotic treatment is contraindicated in acute bronchitis - PRO Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008 Use of antifibrotics in post-COVID ILD: PRO Source: Virtual Congress 2021 – Post COVID interstitial lung diseases syndrome: diagnosis and management as interstitial lung disease? Year: 2021 Long term application of NIV in COPD - PRO & CON Source: ERS course 2015 Year: 2015 Is there a place for oral mucolytics in the prevention of LRTI? - PRO Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new? Year: 2009 PRO recommendation Source: ERS Course 2018 - Noninvasive ventilation: advanced Year: 2018 Survival in IPF acute exacerbations: The non-steroid approach Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 PRO: maintenance is cost-effective Source: Annual Congress 2012 - Pro/Con Debate "Cost-effectiveness of maintenance chemotherapy for NSCLC" Year: 2012 Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)? Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 COPD and pneumonia Source: International Congress 2015 – Different data in COPD Year: 2015 Ventilation management in COVID–19 ARDS vs ARDS from another origin Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Late Breaking Abstract - Azithromycin for acute COPD exacerbations requiring hospitalization – the BACE trial results Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018 Update on management of ARDS Source: Annual Congress 2013 –ME10 Update on management of ARDS Year: 2013 Corticosteroids and acute respiratory distress syndrome (ARDS) Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007